Insulin-like Growth Factor Binding Protein-1(IGFBP-1)
The IGFBP-1 is a ready-to-use in-vitro test kit designed to quantitatively determine the level of IGFBP-1 in human serum in order to diagnose risk pregnancies as well as to prognosticate fetal and postnatal development.
Increased concentrations of IGFBP-1 impair both placental growth and fetal growth and may damage the fetus or lead to a miscarriage. Increased IGFBP-1 concentrations are already detectable 3 to 6 weeks in advance of clinical symptoms such as fetal hypotrophy or hypoxia, pre-eclampsia or intrauterine death of the fetus.
Test Mechanics: Sandwich ELISA principle using monoclonal antibodies
Test Medium: Fetal Serum, Serum of Adults/Children or Amniotic Fluid